Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
65 Cards in this Set
- Front
- Back
t/f
drug permeation across the skin is very fast |
f
slow |
|
t/f
it can take mins for a drug to permeate the entire epidermis |
f
hours |
|
most common routes of transdermal passage
|
transepidermal
transappendageal |
|
appendages
|
hair
sweat glands |
|
which is easier transepidermal or tranappendageal
|
transepidermal
cuz higher surface area |
|
for lipophilic drugs which layers can present a hydrophilic barrier
|
viable layers
|
|
for most drugs once a drug reaches the viable layers it diffuses thru them relatively fast.
why |
they don't have great barrier properties
|
|
upon reaching the ---- systemic absorption is uss fairly quick
|
dermis
after here easy to systemic circulation |
|
once entering an -----, the drug diffuse quickly into the viable epidermis and dermis
|
appendage
|
|
entry thru an ---- allows bypass of SC
|
appendage
|
|
t/f
normally transappendageal transport is a significant pathway for drug transport |
f
not significant because appendages cover a small fraction of the skin surface area |
|
transappen. can be valuable for the permeation of ----- or large --- molecules
|
ions
polar |
|
transappen can act as an early --- for some drugs
|
shunt
|
|
appendage --- varies in different regions of the body
|
densities
|
|
transdermal meds should be ---- and ----
why |
small
lipophilic cuz skin is a lipophilic barrier |
|
drug potency for transderm should be high/low
why? |
high
cuz low blood levels likely |
|
limited application for transdermal patches are about --- to -- days
why |
7-10
cuz they are occlusive block water loss |
|
occlusions due to patches can lead to--- and --- growth
|
maceration
microbial |
|
by increasing skin hydration occlusion can increase drug ----
|
permeability
|
|
skin is often the --- ----- barrier for drug transport
|
rate limiting
|
|
---- enchancers may be part of the drug formulation in a patch
|
penetration
|
|
name a chem that increases SC permeation
how is this done |
ethanol
disrupts stratum corneum lipids . . . basically damages skin |
|
why should you follow the manufacuters' recommendations for placement of the patches
|
due to different SC thickness, different # of shunts
|
|
increase in area, ---- in flux
|
increase
|
|
why are there different nitro patches sizes
|
for different doses of drug
|
|
types of transdermal tx systems
|
matrix
adhesive matrix membrane controlled membrane matrix hybrid |
|
this systems has drug uniformity mixed in w/the matrix
|
matrix
|
|
what type of release is matrix
|
square root
|
|
what controls the drug input in matrix
|
the skin
|
|
what do you need on top of the matrix
|
a lot of impermeability so it won't evaporate
|
|
this type of transdermal the adhesive is a matrix system w/ drug uniformly mixed
|
adhesive matrix
|
|
having the drug in the adhesive leaves one --- layer
|
less
so the patch is thinner |
|
name some meds that have an adhesive matrix
|
climara
testoderm ortho evra lidoderm |
|
where is the testoderm applied
why |
scrotum
5x more permeable than the other sites |
|
where is ortho evra applied
|
upper torso
abd upper outer arm butt |
|
what's ortho evra
|
a contraceptive patch
given q 7 days x 3 wks: 7 days off |
|
this is a relatively large patch for postherpetic neuralgia
|
lidoderm
|
|
t/f
lidoderm patch is used for systemic action |
f
local |
|
t/f
lidoderm can be cut to fit the area |
t
|
|
in membrane controlled the drug is usu formulated as a --- soln and the membrane controls release and can control entry into the -------
|
saturated
circulation |
|
what order is membrane controlled
|
zero order
|
|
t/f
it's possible for the membrane controlled patch to leak |
t
|
|
name some membrane controlled patches
|
estraderm
duragesic androderm |
|
where is estraderm given
|
abd
q 3.5 days |
|
estraderm contains a gelled reservoir of estrogen and ------
|
ethanol
penetration enchancer |
|
duragesic patch contains a ---- reservoir of fentanly and ethanol
|
gelled
|
|
t/f
you can cut duragesic patches |
f
|
|
where is androderm given
|
nonscrotal area
q day |
|
androderm is a -- reservoir system to allow greater amount
|
gel
|
|
membrane matrix hybrid is a --- system in which the rate controllilng membrane gives zero order release to a matrix system
|
combination
|
|
purpose of drug in adhesive of a membrane matrix hybrid
|
to give a burst
or to saturate skin binding sites |
|
name two meds that have a membrane matrix hybrid system
|
catapress tts
transdermscop |
|
where is catapres given
|
upper arms
torso q 7 days |
|
in catapres the drug is inthe adhesive to saturate the binding site this will lead to. . .
|
therapeutic levels in 2-3 days
|
|
where is transdermscop give
why |
behind ear
thin SC and more shunts |
|
transdermscop will have tx levels in - hrs
|
4
|
|
Iontophoresis uses ---- to drive drug molecules contained in reservoirs thru the skin
|
electricity
|
|
t/f
ionotophoresis is the same as electrophoresis |
f
|
|
why will current pass thru the viable epidermis
|
due to water content
|
|
iontophoresis wil possible ----- and disrupted intracellular ----
|
shunts
lipids |
|
t/f
iontophoresis is only for charged drugs |
f
mainly for charged but also for noncharged |
|
how is iontophoresis useful for noncharged
|
cuz it causes solvent flow
|
|
name a med that uses the ionophoresis system
|
numbystuff: delivers lido and epi
|
|
t/f
iontophoresis is only for local purposes |
f
can also be for systemic |
|
the current forces the drug to the viable epidermis where it can diffuse to ----- and ------
|
tissues
capillaries |